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Inherited retinal dystrophies are characterized by progressive retina degeneration and mutations 
in at least 250 genes have been associated as disease-causing. CRB1 is one of many genes analyzed 
in molecular diagnosis for inherited retinal dystrophy. Crumbs homolog-1 protein encoded by 
CRB1 is important for cell-to-cell contact, polarization of epithelial cells and the morphogenesis of 
photoreceptors. Pathogenic variants in CRB1 lead to a huge variety of phenotypes ranging from 
milder forms of inherited retinal dystrophy, such as retinitis pigmentosa to more severe phenotypes 
such as Leber congenital amaurosis. In this study, seven novel likely-pathogenic variants were 
identified: four missense variants (p.Leu479Pro, p.Ala921Pro, p.Cys948Arg and p.Asp1031Asn), 
two frameshift deletions (c.2536_2542del7 and c.3460_3461delTG) and one frameshift indel variant 
(c.276_294delinsTGAACACTGTAC). Furthermore, two patients with cone-rod dystrophy due to 
mutations in CRB1 were reported, supporting previous data, in which mutations in CRB1 can also cause 
cone-rod dystrophy. Finally, our data suggested there was a direct relation between phenotype severity 
and the mutation effect on protein functionality in 15 Brazilian CRB1 patients.
The CRB1 gene is associated with some inherited retinal dystrophies (IRD). In humans, it is located on chromo-
some 1q31.3, composed of 12 exons and encodes a protein with 1406 amino acids, called Crumbs homolog-1. 
This protein participates in a conserved protein network involved in the morphogenesis of photoreceptors and 
the establishment and maintenance of apico-basal polarization and adherent junctions of epithelial cells1–3.
Crumbs homolog-1 is in a subapical region of photoreceptors, it has a large extracellular part composed of 19 
epidermal growth factor (EGF)-like domains and 3 laminin A globular (AG)-like domains, one transmembrane 
segment and a small cytoplasmic domain. The intracellular domain has a juxtamembrane FERM-binding motif 
and a carboxy-terminal PDZ-binding motif, by means of which CRB1 interacts with other proteins forming a 
complex that participates in adherent junction formation and links to cytoskeletons3, 4.
Mutations in CRB1 lead to retinal abnormalities such as thickening, coarse lamination patterns and loss of 
photoreceptor signalling1. Currently, more than 200 mutations in CRB1 have been cited in the Human Gene 
Mutation Database - HGMD5. The main diseases caused by mutations in CRB1 are: retinitis pigmentosa (RP) 
either with or without paraarteriolar preservation of retinal pigment epithelium (PPRPE), Leber congenital 
amaurosis (LCA) and pigmented paravenous chorioretinal atrophy6, 7.
In this study, a large number of medical records of IRD Brazilian patients were reviewed, where 15 patients 
with CRB1 mutations were selected, and two of them presented cone-rod dystrophy (CRD). Seven new 
disease-causing variants were reported and a direct relation between phenotype severity and the impact on pro-
tein functionality caused by mutation was observed.
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Results
Among the 230 medical records of IRD patients analyzed, 15 cases of unrelated patients with CRB1 variants were 
selected, where 13 of them had conclusive molecular diagnosis, whereas in the other two, only one variant was 
found, presenting a non-conclusive molecular diagnosis. All 15 patients received clinical diagnoses, wherein 
eight of them were diagnosed as LCA, three as RP, two as CRD and two as early-onset retinal dystrophy (EORD).
Clinical findings. All eight patients with LCA exhibited the initial symptoms before the first year after birth. 
Low vision and nystagmus were the most striking features of this group. Only patient 5 did not present nys-
tagmus. Visual acuity of LCA patients ranged from: reduced vision (patient 1) to severe visual loss (patient 4) 
(Table 1). The typical nummular pigmentation and macular atrophy could be observed from the fundus photo-
graphs. In some of them, there was a yellow deposit present in the macular area and widespread white dots in the 
retinal pigment epithelium (RPE) (Fig. 1a and Supplementary Figure S1).
Four patients had showed the first signs and symptoms since their childhood. No nystagmus was present 
in any of them. Patient 9 with EORD had peripheral vision impairment (tunnel vision) with nummular pig-
mentation in the RPE and, patient 10 had a central vision impairment, midperiphery with bone spicules and 
granular pigmentation in the RPE (Supplementary Figure S2). On the other hand, patients diagnosed with CRD 
(11 and 12) had a more severe impairment of central vision (Table 1) and the fundus examination showed bone 
spicules with perivascular pattern, as well as macular atrophy characteristics of CRD (Fig. 1b and Supplementary 
Figure S2). In addition, patient 12 presented an atypical fundus pattern for cone-rod dystrophies, with a 
well-delimited hyperfluorescent area (Supplementary Figure S3).
As expected for the RP group, the first signs and symptoms appeared either during adolescence or later, and 
the absence of nystagmus was common in all, with visual acuity 20/80 or less (Table 1). Fundus analysis showed 
macular preservation compatible with their visual acuity, granular pigments in the RPE and the peripheral pres-
ence of bone spicules (Fig. 1c and Supplementary Figure S2). Only patient 13 had RP with PPRPE.
In relation to vascular aspects, patients 2, 4, 6 and 9 showed increased vascular tortuosity. The increased vas-
cular permeability compatible with Coats-like disease onset was noted in two patients with LCA (patient 1 and 
8), two with RP (patients 13 and 15), one with EORD (patient 10) and another with CRD (patient 11). Leakage 
of fluid and blood in Coats-like diseases usually occurs in peripheral vessels, but it may also occur in the macula, 
causing cystoid macular edema, as observed in patient 15 (Fig. 1d).
Genetic findings. Table 2 shows the genotypes of patients in this study. All presented variants are classified 
as pathogenic according to HGMD5, except the new variants, highlighted in bold. Patients 14 and 15 did not have 
a conclusive molecular result because the second pathogenic CRB1 variant was not found. Ten patients of the 13 
genetically concluded cases are compound heterozygotes, whereas the remaining three are homozygotes (patients 
3, 8 and 11). In addition, patient 11 is descended from a consanguineous marriage.
Interestingly, all LCA subjects have more severe pathogenic variants in both alleles. These variants cause 
premature termination or structural change of the protein due to loss of cysteines involved in disulfide bond 
Patient Signs and Symptoms




Diagnosis Visual Acuities (OD; OS)
Clinical 
Diagnosis
1 Nystagmus; Reduced visual acuity improved with the development of patient. first year of life 27 20/60; 20/100 LCA
2 Nystagmus since birth 6 months good fix and follow behavior LCA
3 Nystagmus; Deep reduced visual acuity; mild enophthalmos. since birth 27 20/1600; 20/1600 LCA
4
Nystagmus; Severe visual loss; Minimum residual 
temporal visual field in the right eye; Divergent 
strabismus in the left eye.
first year of life 20 Counting fingers LCA
5 Non-Nystagmus; Reduced visual acuity; Intermittent exotropia since birth 7 20/200; 20/200 LCA
6 Nystagmus 3 months of life 3 hand movements perception LCA
7 Nystagmus; Sub-normal vision 2 months of life 2 20/200; 20/200 LCA
8 Nystagmus; Progressive reduced visual acuity first year of life 16 20/80; 20/50 LCA
9 Non-Nystagmus; Tubular visual field; Strabismus 5 years old 10 20/60; 20/60 EORD
10 Non-Nystagmus; Reduced visual acuity; Nyctalopia 6 years old 12 20/400; 20/400 EORD
11 Non-Nystagmus in the beginning; Nyctalopia 9 years old 9 temporal perception of light and light movement CRD
12 Non-Nystagmus; Reduced central visual acuity. 7 years old 24 20/200; 20/400 CRD
13 Non-Nystagmus; Reduced visual acuity even with glasses; Tubular visual field; Nyctalopia adolescence 18 20/80; 20/80 RP
14
Non-Nystagmus; Convergent strabismus; Hearing 
loss; Myopia; Glaucoma; Tubular visual field; 
Nyctalopia
adolescence 47 20/40; 20/25 RP
15 Non-Nystagmus; Tubular visual field; Nyctalopia adulthood 59 20/20; 20/30 RP
Table 1. Clinical Data of CRB1 patients.
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formation. In our study, two cysteines forming disulfide bonds are affected: Cys948 and Cys1154. On the other 
hand, RP and CRD patients have mostly missense variants that do not affect cysteines involved in disulfide bonds. 
The only exception was patient 14, who has one in-frame deletion with loss of three amino acids (Ile-Asp-Gly), 
which does not induce formation of a premature stop codon.
Sixteen different variants in CRB1 were found in these subjects. All of them are located in protein domains 
(Laminin(AG)-like or EGF-like domains) in crumbs homolog-1 extracellular segment, the only exception was 
p.Arg1390* variant that is in the cytoplasmic domain (Fig. 2). The variants found in this study are preferably 
located in exons 2, 7 and 9 (three variants at exon 2 and 7 and five variants at exon 9). p.Cys948Tyr was the most 
frequent in this study (7 alleles in 30 analyzed) (Table 3).
Seven subjects presented new changes in the CRB1 gene, wherein four novel missense variants were found 
(p.Leu479Pro, p.Ala921Pro, p.Cys948Arg and p.Asp1031Asn), two frameshift deletions (c.2536_2542del7 and 
c.3460_3461delTG) and one frameshift indel variant (c.276_294delinsTGAACACTGTAC) (see Table 4). None 
of them were present in the ClinVar8, ESP9, ExAC10 and 1000 Genomes Project11 databases. All new frameshift 
variants occur in the extracellular domain, leading to premature termination of the protein with the loss of the 
transmembrane region, contrasting with data found in patient 9 (p.Arg1390*) where protein truncation caused 
the loss of the PDZ-binding motif but the transmembrane domain was preserved.
In silico analysis of new missense variants showed that, they were classified as likely pathogenic for at least two 
predictors (Table 4). In comparison with other species, it is noted that amino acids changed are highly conserved 
(Fig. 3), mainly among primates (first 12 species of Fig. 3).
All novel variants found in this study can be classified as likely pathogenic according to the criteria of effect 
in the protein structure, amino acid conservation, frequency in population and classification by pathogenic pre-
dictors (Table 4).
Discussion
Mutations in the CRB1 gene lead to visual impairment and even complete blindness in individuals with many dif-
ferent clinical IRD phenotypes, including LCA, EORD and RP6, 12–14. Despite the large phenotypic heterogeneity 
Figure 1. Fundus appearance from CRB1 patients. (a) Color fundus photograph of LCA patient showing the 
nummular pigmentation and macular atrophy. (b) Color fundus photograph of CRD patient showing macular 
atrophy. (c) Color fundus photograph of RP patient showing RPE atrophy and macular area perverted. (d) 
Fluorescein Angiography with fluorescein leakage in peripheral vessels and at the macula. Yellow arrows 
indicate bone spicules and white arrows indicate leakage of fluorescein.
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among CRB1 patients, some signs, symptoms and ophthalmologic findings can be observed with more fre-
quency12. Overall, the subjects in this study presented many of typical characteristics including: nummular pig-
mentation, macular atrophy, bone spicules, nystagmus and poor central vision in patients with LCA and macular 
preservation, peripheral bone spicules, pigmentation changes of the RPE, nyctalopia and tunnel vision in typical 
RP patients.
In two cases (patients 14 and 15), the molecular result was not conclusive because only one pathogenic variant 
was found. As the inheritance pattern of IRD caused by CRB1 mutations is autosomal recessive, then the presence 
of pathogenic variants in both alleles are required for the molecular test to be conclusive. While advances in the 
molecular diagnosis of IRD are moving fast, the next-generation sequencing still do not solve 35–45% of IRD 
cases15–18.
In the past, negative or inconclusive diagnoses have occurred through the screening of known mutations, such 
as in patient 15, tested by DNA microarray (APEX). The Sanger sequencing technique subsequently allowed for 
an improved analysis of specific genes and identification of known and new variants, such was the case of patients 
1, 3, 4, 13 and 14.
Sanger sequencing of patient 14 identified, in addition to the pathogenic variant (c.498_506del9 - p.Ile167_
Gly169del), a further three heterozygous variants: c.849-35 T > C (rs1337167), c.989-53 G > T (rs2786098) and 
c.*28 T > C (rs41302107). They are not rare in population databases10, 11 and considered likely benign8, 19. Conte 
and coworkers (2015) showed that retinal dystrophy could be caused by mutations in seed regions of miRNA20. 
Therefore, the 3′UTR variant was analyzed in PolymiRTS Database 3.021 and TargetScan v.7.022 to identify 
whether it could cause changes in miRNAs or in those target regions. The c.*28 T > C variant possibly changed 
some miRNA binding sites, as shown in Supplementary Figure S4. Changes in miRNA binding sites may affect 
CRB1 expression and contribute to the patient’s phenotype. However, the real effect of this change requires further 
investigation.
Two CRD patients showed likely pathogenic variants in CRB1 gene. CRD is caused by mutation in many genes 
such as ABCA4, ADAM9, C8orf37, CDHR1, CRX, DRAM2, GUCA1A, GUCY2D, PITPNM3, POC1B, PROM1, 
RAB28, RAX2, RIMS1, RPGRIP1, SEMA4A, and TTLL56. Genetic reference databases, including OMIM6 and 
RetNet7, do not indicate an association between CRB1 and CRD. Up to now, only three studies have found this 
causal relationship, with one describing three unrelated subjects23, another, a consanguineous nuclear family24 
and the third, one proband with a novel splice-site mutation25. Our data supports the hypothesis that CRB1 can 
also cause CRD and thus the CRB1 gene might be included in target list for CRD genetic testing.
CRB1 mutations are considered a risk factor in the development of Coats-like vasculopathy13, 26, and, because 
of this, retinal vascular characteristics should be always evaluated in CRB1 patients. Among 15 patients analyzed 
in this study, approximately 67% showed vascular abnormalities such as: vascular tortuosity, arteriolar sclerosis, 
increased vascular permeability and leakage of fluid and blood, which may mean the beginning of a Coats-like 
disease. An interesting aspect to note is that mutations in CRB1 can cause osteoclast deposition on top of vessels 
or in the paravenous region (Fig. 1). It was not possible to associate these vascular phenotypes with a specific 
retinal dystrophy or specific mutation in these subjects, corroborating data in the literature which states that 
Coats-like vasculopathy does not develop solely in RP patients13, 23, 27.
Bujakowska and coworkers (2012) published an extensive review of CRB1 cases, showing that exons 7 and 9 
have the highest concentration of pathogenic variants, and p.Cys948Tyr is the most frequent of them13. Our find-
ings are similar to these, approximately 69% of variants found in this study are located in the exons 2, 7 and 9 and 
p.Cys948Tyr is also the most frequent in our samples - it was present in 23% of alleles analyzed.
Interestingly, patient 6 has two different missense variants in the same codon (p.Cys948Tyr and p.Cys948Arg). 
p.Cys948Arg is not described in literature and also it was found in patient 7. Cysteines have an important role 
Patient
Allele 1 Allele 2 Clinical 
DiagnosisNucleotide Change Protein Change Nucleotide Change Protein Change
1 c.2843 G > A p.Cys948Tyr c.3676 G > T p.Gly1226* LCA
2 c.2536_2542del7 p.Gly846Serfs*8 c.2843 G > A p.Cys948Tyr LCA
3 c.984 G > A p.Trp328* c.984 G > A p.Trp328* LCA
4 c.2536_2542del7 p.Gly846Serfs*8 c.2843 G > A p.Cys948Tyr LCA
5 c.984 G > A p.Trp328* c.2843 G > A p.Cys948Tyr LCA
6 c.2842 T > C p.Cys948Arg c.2843 G > A p.Cys948Tyr LCA
7 c.2842 T > C p.Cys948Arg c.3460_3461delTG p.Cys1154* LCA
8 c.2843 G > A p.Cys948Tyr c.2843 G > A p.Cys948Tyr LCA
9 c.2291 G > A p.Arg764His c.4168 C > T p.Arg1390* EORD
10 c.276_294delinsTGAACACTGTAC p.Arg92Serfs*54 c.2506 C > A p.Pro836Thr EORD
11 c.1436 T > C p.Leu479Pro c.1436 T > C p.Leu479Pro CRD
12 c.2761 G > C p.Ala921Pro c.3091 G > A p.Asp1031Asn CRD
13 c.2506 C > A p.Pro836Thr c.3320 T > G p.Leu1107Arg RP
14 c.498_506del9 p.Ile167_Gly169del not found not found RP
15 c.614 T > C p. Ile205Thr not found not found RP
Table 2. Genotypes of patients with CRB1 variants. The novel variants are indicated in bold.
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c.276_294delinsTGAACACTGTAC (p.Arg92Serfs*54) 2 Extracellular EGF 2 not reported 1/30
c.498_506del9 (p.Ile167_ Gly169del) 2 Extracellular EGF 4 LCA, RP, Stargardt (CD061397) 1/30
c.614 T > C (p. Ile205Thr) 2 Extracellular EGF 5 RP, LCA (CM033359) 1/30
c.984 G > A (p.Trp328*) 4 Extracellular EGF 8 LCA (CM1310165) 3/30
c.1436 T > C (p.Leu479Pro) 6 Extracellular EGF 11 not reported 2/30
c.2291 G > A (p.Arg764His) 7 Extracellular Laminin AG 2 RP (CM130791) 1/30
c.2506 C > A (p.Pro836Thr) 7 Extracellular Laminin AG 2 RP (CM043271) 2/30
c.2536_2542del7 (p.Gly846Serfs*8) 7 Extracellular Laminin AG 2 not reported 2/30
c.2761 G > C (p.Ala921Pro) 8 Extracellular EGF 13 not reported 1/30
c.2842 T > C (p.Cys948Arg) 8 Extracellular EGF 14 not reported 2/30
c.2843 G > A (p.Cys948Tyr) 9 Extracellular EGF 14 RP, LCA, EORD (CM992152) 7/30
c.3091 G > A (p.Asp1031Asn) 9 Extracellular Laminin AG 3 not reported 1/30
c.3320 T > G (p.Leu1107Arg) 9 Extracellular Laminin AG 3 LCA (CM057656) 1/30
c.3460_3461delTG (p.Cys1154*) 9 Extracellular EGF 15 not reported 1/30
c.3676 G > T (p.Gly1226*) 9 Extracellular EGF 17 LCA (CM113150) 1/30
c.4168 C > T (p.Arg1390*) 12 Cytoplasmic none RP (CM130803) 1/30
Table 3. Variants Data. †Allele frequency in this study.
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in structure and function of proteins, and variations in this residue are highly likely to cause deleterious pheno-
types, especially if the mutated cysteine is part of disulfide bonds28, as well as in Cys948 in crumbs homolog-1 
protein. Mutations at codon 948 affect the correct folding of 14th EGF-like domain29. A large number of exonic 
variants, missense or synonymous, have already been shown to possess disease-causing effects by disrupting 
the pre-mRNA’s editing process, causing aberrant splicing30–32. Both variants were analyzed in Human Splicing 
Finder33, which indicated them as potential alterations of splicing. Perhaps the greatest deleterious effect caused 
by changes in 948th codon is not due to the exchange of a conserved cysteine but to mRNA processing problems.
Our data shows a striking pattern between mutation type and the patient’s phenotype. Individuals with severe 
retinal dystrophy, such as LCA, have two variants affecting the protein function or structure most severely (e.g. 
frameshift changes, premature stop codon formation, aberrant splicing and lack of disulfide bond, due to mutated 
cysteine). On the other hand, patients with milder IRD have missense variants or in-frame deletions. Patient 
9 and 10 with EORD have an intermediate phenotype and genotype, i.e. a missense variant (p.Arg764His and 
p.Pro836Thr respectively) and a premature truncation (p.Arg1390* and p.Arg92Serfs*54 respectively). Despite 
the fact that a genotype-phenotype relationship has not been clearly established in previous studies, they also 
noted that patients with more severe phenotypes, for example macular atrophy, tend to have protein truncation 
(nonsense or frameshift deletions) and/or p.Cys948Tyr variants13, 23, 26.
To establish a genotype-phenotype correlation in CRB1 patients is not an easy task. There is a substantial 
phenotypic overlap and variability between CRB1-related diseases and a small number of patients with muta-
tions in this gene. Moreover, the phenotypic modulation possibly occurs due to environmental factors and other 
genetic factors12, 13, 26, 34, 35, such as unknown genes, silent variants causing aberrant splicing36, deep intronic muta-
tions36–38, copy number variations39, complex genomic rearrangements40, 41, multigenic inheritance patterns, 
genetic modifiers42–44 and regulators of gene expression20, 45. In addition, technical limitations, such as uncovered 
or low-depth regions in NGS analysis, may hinder the correct molecular diagnosis46.
Nucleotide Change Protein Change Effect
in silico Analysis
PathogenicityPoly-Phen2† PROVEAN SIFT
c.276_294delinsTGAACACTGTAC p.Arg92Serfs*54 Frameshift/protein truncation — — — Likely pathogenic
c.1436 T > C p.Leu479Pro Change of highly conserved residue D D T Likely pathogenic
c.2536_2542del7 p.Gly846Serfs*8 Frameshift/protein truncation — — — Likely pathogenic
c.2761 G > C p.Ala921Pro Change of highly conserved residue D D T Likely pathogenic
c.2842 T > C p.Cys948Arg Change of highly conserved residue D D D Likely pathogenic
c.3091 G > A p.Asp1031Asn Change of highly conserved residue D D D Likely pathogenic
c.3460_3461delTG p.Cys1154* Frameshift/protein truncation — — — Likely pathogenic
Table 4. Novel likely-pathogenic variants in CRB1 gene identified in this study. †Poly-Phen2 HumVar; D – 
Probably Damaging; T – Tolerated.
Figure 3. Amino acid conservation analysis of novel missense variants identified in this study.
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Nowadays, molecular diagnoses are strongly orienting clinical practice in cases of IRD, where there is high gen-
otype and phenotype heterogeneity. The more that new mutations are described and new genotypic-phenotypic 
associations are made, the greater the knowledge regarding these diseases. Our study highlighted a direct relation 
between phenotype severity and the mutation effect on protein functionality in CRB1 Brazilian patients, con-
tributing to current knowledge about disease-causing variants and supporting the association between the CRB1 
gene and cone-rod dystrophy.
Methods
This retrospective study reviewed 230 medical records of Brazilian patients with IRD assisted at the Universidade 
Federal de São Paulo and Instituto de Genética Ocular in São Paulo, Brazil between January 2006 and February 
2017. The condicio sine qua non to include patients was that they must have already performed at least one genetic 
test for IRD. Table 5 shows the commercial genetic tests performed on each CRB1 patient.
In addition to the genetic data, medical history and eye exams were collected. The clinical hypothesis for 
patient classification of patients was created based on their signs and symptoms, age of onset and fundus features.
The classification of new variants according to pathogenicity was based on the following criteria: variants 
with the most potential to cause disease are those that result in truncated protein production (premature stop 
codon and frameshift changes) or missense changes in highly conserved amino acids, as well as a rare frequency 
variation in genetic population databases and classified as likely damaging by the pathogenicity predictors. 
The databases consulted were: HGMD5, ExAC10, 1000 Genomes Project11, Exome Sequencing Project (ESP)9 
and ClinVar8. The pathogenicity predictor softwares consulted were: Poly-Phen247, SIFT48 and PROVEAN49. 
Combined Annotation Dependent Depletion (CADD) software19 was used to evaluate changes in non-coding 
regions of the CRB1 gene. The Human Splicing Finder33 was used to check possible aberrant splicing. The bio-
informatics tools PolymiRTS Database 3.021 and TargetScan v.7.022 were used to evaluate changes in miRNAs or 
miRNA binding sites.
For amino acid conservation analysis, CRB1 gene of 38 species was compared. A multiple sequence alignment 
was built using PRALINE online toolkit50, where all previous selected sequences were submitted to multiple 
alignment using default parameters. The alignment file was open in Clustal X51 in order to build alignment fig-
ures. The amino acids were classified as: highly conserved (changed in a maximum of three species), moderately 
conserved (changed in four to six species) and weakly conserved (changed in more than six species).
Nucleotide numbering is based on reference sequence NM_201253, where A of initiation codon (ATG) is the 
number 1.
The Ethics Committee in Research of Federal University of São Paulo approved this study (CEP: 0415/2016). 
Written informed consent for the use of personal medical data for scientific purposes and publication was 
obtained from all patients and/or their legal guardians. In addition, this study was performed in accordance with 
the ethical standards of the 1964 Declaration of Helsinki and its subsequent amendments.
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